Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study.
Chloé CouretPierre-Antoine QuintartAlexandra PoinasMarie-Anne VibetMarie-Laure Le LezPierre LabaletteBahram BodaghiMarc LabetoulleMarie-Bénédicte RougierKarine AngioiChristophe ChiquetCherif TitahLaurent KodjikianStephanie BaillifCatherine Creuzot-GarcherMarie-Hélène ErreraMichel WeberPublished in: The British journal of ophthalmology (2024)
We could not demonstrate the non-inferiority of triamcinolone injections at month 2. Nevertheless, they showed some efficacity, particularly in treating postoperative ME, being as safe as dexamethasone injections, without any loss of chance if a therapeutic switch is necessary.